Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & Administrative
Others
Ratios

AC Immune (ACIU) Other Non Operating Income (2020 - 2025)

Historic Other Non Operating Income for AC Immune (ACIU) over the last 8 years, with Q3 2025 value amounting to -$15000.9.

  • AC Immune's Other Non Operating Income rose 9951.36% to -$15000.9 in Q3 2025 from the same period last year, while for Sep 2025 it was -$764917.3, marking a year-over-year increase of 8648.27%. This contributed to the annual value of -$1.8 million for FY2024, which is 1029.87% down from last year.
  • Latest data reveals that AC Immune reported Other Non Operating Income of -$15000.9 as of Q3 2025, which was up 9951.36% from -$2.7 million recorded in Q2 2025.
  • Over the past 5 years, AC Immune's Other Non Operating Income peaked at $2.2 million during Q4 2024, and registered a low of -$3.1 million during Q3 2024.
  • Over the past 5 years, AC Immune's median Other Non Operating Income value was -$17794.8 (recorded in 2023), while the average stood at -$309151.1.
  • Within the past 5 years, the most significant YoY rise in AC Immune's Other Non Operating Income was 345148.63% (2024), while the steepest drop was 1546019.54% (2024).
  • Over the past 5 years, AC Immune's Other Non Operating Income (Quarter) stood at -$405603.8 in 2021, then surged by 72.1% to -$113144.4 in 2022, then plummeted by 1361.7% to -$1.7 million in 2023, then soared by 235.63% to $2.2 million in 2024, then plummeted by 100.67% to -$15000.9 in 2025.
  • Its Other Non Operating Income stands at -$15000.9 for Q3 2025, versus -$2.7 million for Q2 2025 and -$324777.2 for Q1 2025.